Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06691971 · ClinicalTrials.gov registry record
AeviceMD for Detection of Wheeze in Pediatric and Adult Populations
A clinical trial of Asthma and Pediatric Asthma, sponsored by Aevice Health Pte..
- Recruiting
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT06691971: Recruiting study of Asthma and Pediatric Asthma, sponsored by Aevice Health Pte..
NCT06691971 is a study of Asthma and Pediatric Asthma that is actively recruiting participants, run by Aevice Health Pte.. The registered enrollment target is 160 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06691971, a study of Asthma and Pediatric Asthma, is actively recruiting participants, sponsored by Aevice Health Pte..
- RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.
Primary Outcome
Primary endpoint of wheeze will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation. AeviceMD will perform wheeze analysis on each 5 sec of recording.
Conditions Studied
Interventions
- DEVICE AeviceMD
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-06-29 |
| Est. Completion | 2026-12 |
What NCT06691971 shows while recruiting
NCT06691971 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower).
The record links to 6 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which AeviceMD is the first listed.
NCT06691971 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06691971 about?
NCT06691971 is a clinical study titled "AeviceMD for Detection of Wheeze in Pediatric and Adult Populations". Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing va...
What is the current status of trial NCT06691971?
This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2023-06-29. Estimated completion is 2026-12.
What conditions does trial NCT06691971 study?
This clinical trial studies the following conditions: Asthma, Pediatric Asthma, Respiratory Tract Diseases, Chronic Respiratory Disease, Subject Presenting Wheeze.
What interventions are being tested in trial NCT06691971?
The interventions under investigation include: AeviceMD (DEVICE).
Who is sponsoring clinical trial NCT06691971?
This trial is sponsored by Aevice Health Pte., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06691971 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06691971's enrollment target sits among peer trials
160 181st of 374 higher than 193 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI